Genesee Capital Advisors’s ASML ASML Stock Holding History

Genesee Capital Advisors’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Buy	+109	New	+$173K	0.07%	157

Other funds holding ASML

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Genesee Capital Advisors's ASML Position: Q2 2026 in Review

Genesee Capital Advisors opened a new position in ASML (ASML) in Q2 2026: 109 shares worth $217K. The stake represents 0.07% of the portfolio and ranks #157 among its holdings.

2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

Genesee Capital Advisors held 109 shares of ASML worth $217K as of Q2 2026.
ASML was a new Genesee Capital Advisors position in Q2 2026.
ASML made up 0.07% of Genesee Capital Advisors's portfolio in Q2 2026, its #157 holding.
2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Genesee Capital Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.